Skip to content
← Full study record

NCT00365053 · MORE INFO

Limitations, agreements, and source contact

PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery · Source last updated 2018-06-07

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
CCCP@coh.org
organization
California Cancer Consortium
phone
626-256-4673
phone Ext
60094
title
DCC Project Administrator
Complete source fields
certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
CCCP@coh.org
organization
California Cancer Consortium
phone
626-256-4673
phone Ext
60094
title
DCC Project Administrator

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice